Human leukocyte antigen‑G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment (Review)
- Authors:
- Yanwen Zhang
- Shuwen Yu
- Yali Han
- Yunshan Wang
- Yuping Sun
-
Affiliations: Department of Oncology, School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Pharmacy, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China, Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China, Medical Research and Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China - Published online on: November 14, 2017 https://doi.org/10.3892/ol.2017.7407
- Pages: 699-709
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Carosella ED, Favier B, Rouas-Freiss N, Moreau P and Lemaoult J: Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood. 111:4862–4870. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Amiot L, Ferrone S, Grosse-Wilde H and Seliger B: Biology of HLA-G in cancer: A candidate molecule for therapeutic intervention? Cell Mol Life Sci. 68:417–431. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang F, Zhao H, Wang L, Guo X, Wang X, Yin G, Hu Y, Li Y and Yao Y: Role of HLA-G1 in trophoblast cell proliferation, adhesion and invasion. Biochem Biophys Res Commun. 458:154–160. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rouas-Freiss N, Kirszenbaum M, Dausset J and Carosella ED: Fetomaternal tolerance: Role of HLA-G molecule in the protection of the fetus against maternal natural killer activity. C R Acad Sci III. 320:385–392. 1997.(In French). View Article : Google Scholar : PubMed/NCBI | |
|
Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG and Carosella ED: HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA. 95:pp. 4510–4515. 1998; View Article : Google Scholar : PubMed/NCBI | |
|
Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P and Donadi EA: A comprehensive study of polymorphic sites along the HLA-G gene: Implication for gene regulation and evolution. Mol Biol Evol. 28:3069–3086. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED and Moreau P: The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol. 64:1005–1010. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Castelli EC, Mendes-Junior CT, Deghaide NH, de Albuquerque RS, Muniz YC, Simões RT, Carosella ED, Moreau P and Donadi EA: The genetic structure of 3′untranslated region of the HLA-G gene: Polymorphisms and haplotypes. Genes Immun. 11:134–141. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hylenius S, Andersen AM, Melbye M and Hviid TV: Association between HLA-G genotype and risk of pre-eclampsia: A case-control study using family triads. Mol Hum Reprod. 10:237–246. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pandey MK, Rani R and Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 272:95–108. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tahan F and Patiroglu T: Plasma soluble human leukocyte antigen G levels in asthmatic children. Int Arch Allergy Immunol. 141:213–216. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Consiglio CR, Veit TD, Monticielo OA, Mucenic T, Xavier RM, Brenol JC and Chies JA: Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens. 77:540–545. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gazit E, Slomov Y, Goldberg I, Brenner S and Loewenthal R: HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol. 65:39–46. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Dias FC, Castelli EC, Collares CV, Moreau P and Donadi EA: The Role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral hepatitis, and parasitic diseases. Front Immunol. 6:92015. View Article : Google Scholar : PubMed/NCBI | |
|
Koller BH, Geraghty DE, DeMars R, Duvick L, Rich SS and Orr HT: Chromosomal organization of the human major histocompatibility complex class I gene family. J Exp Med. 169:469–480. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Morandi F and Pistoia V: Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions. Front Immunol. 5:3942014. View Article : Google Scholar : PubMed/NCBI | |
|
Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P and LeMaoult J: HLA-G: An immune checkpoint molecule. Adv Immunol. 127:33–1444. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J and Rouas-Freiss N: HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol. 81:199–252. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Fujii T, Ishitani A and Geraghty DE: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 153:5516–5524. 1994.PubMed/NCBI | |
|
Park GM, Lee S, Park B, Kim E, Shin J, Cho K and Ahn K: Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun. 313:606–611. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ishitani A and Geraghty DE: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA. 89:pp. 3947–3951. 1992; View Article : Google Scholar : PubMed/NCBI | |
|
Curigliano G, Criscitiello C, Gelao L and Goldhirsch A: Molecular pathways: Human leukocyte antigen G (HLA-G). Clin Cancer Res. 19:5564–5571. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, Maenaka K, Stuart DI, Jones EY, van der Merwe PA, Bell JI and Jakobsen BK: Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem. 275:15232–15238. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V and Rolink A: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:3096–3100. 1998.PubMed/NCBI | |
|
Borges L and Cosman D: LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11:209–217. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Yan WH and Fan LA: Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res. 15:176–182. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED and Alegre E: The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 49:63–84. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liang S, Ristich V, Arase H, Dausset J, Carosella ED and Horuzsko A: Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA. 105:pp. 8357–8362. 2008; View Article : Google Scholar : PubMed/NCBI | |
|
Ketroussi F, Giuliani M, Bahri R, Azzarone B, Charpentier B and Durrbach A: Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway. PLoS One. 6:e227762011. View Article : Google Scholar : PubMed/NCBI | |
|
LeMaoult J, Zafaranloo K, Le Danff C and Carosella ED: HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK, cells and T cells. FASEB J. 19:662–664. 2005.PubMed/NCBI | |
|
Gooden MJ and van Hall T: Infiltrating CTLs are bothered by HLA-E on tumors. Oncoimmunology. 1:92–93. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
LeMaoult J, Krawice-Radanne I, Dausset J and Carosella ED: HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA. 101:pp. 7064–7069. 2004; View Article : Google Scholar : PubMed/NCBI | |
|
Ibrahim EC, Aractingi S, Allory Y, Borrini F, Dupuy A, Duvillard P, Carosella ED, Avril MF and Paul P: Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer. 108:243–250. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H and Reinhold U: Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer. 92:369–376. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
da Silva GB, Silva TG, Duarte RA, Neto NL, Carrara HH, Donadi EA, Gonçalves MA, Soares EG and Soares CP: Expression of the Classical and Nonclassical HLA molecules in breast cancer. Int J Breast Cancer. 2013:2504352013. View Article : Google Scholar : PubMed/NCBI | |
|
Elliott RL, Jiang XP, Phillips JT, Barnett BG and Head JF: Human leukocyte antigen G expression in breast cancer: Role in immunosuppression. Cancer Biother Radiopharm. 26:153–157. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED and Paul P: Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol. 196:266–274. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, Cao FL, Zhang JG and Yan WH: Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol. 71:892–898. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
He X, Dong DD, Yie SM, Yang H, Cao M, Ye SR, Li K, Liu J and Chen J: HLA-G expression in human breast cancer: Implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol. 17:1459–1469. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ and Kuppen PJ: HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol. 185:7452–7459. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ramos CS, Gonçalves AS, Marinho LC, Gomes Avelino MA, Saddi VA, Lopes AC, Simões RT and Wastowski IJ: Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma. Hum Immunol. 75:667–672. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sayed D, Badr G, Maximous D, Mikhail NN, Abu-Tarboush F and Alhazza IM: HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients. Tissue Antigens. 75:40–47. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong S, Park S, Park BW, Park Y, Kwon OJ and Kim HS: Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients. PLoS One. 9:e982842014. View Article : Google Scholar : PubMed/NCBI | |
|
Provatopoulou X, Kalogera E, Sagkriotis A, Zagouri F, Nonni A, Zografos GC and Gounaris A: Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy. Anticancer Res. 32:1021–1026. 2012.PubMed/NCBI | |
|
Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R and Trojan A: Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol. 159:817–824. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM: Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer. 58:267–274. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lin A, Zhu CC, Chen HX, Chen BF, Zhang X, Zhang JG, Wang Q, Zhou WJ, Hu W, Yang HH, et al: Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer. J Cell Mol Med. 14:2318–2329. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schütt P, Schütt B, Switala M, Bauer S, Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn PA and Rebmann V: Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol. 71:489–495. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Cao M, Yie SM, Liu J, Ye SR, Xia D and Gao E: Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens. 78:120–128. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J and Fan J: Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res. 15:4686–4693. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lin A, Chen HX, Zhu CC, Zhang X, Xu HH, Zhang JG, Wang Q, Zhou WJ and Yan WH: Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med. 14:2162–2171. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Ye Z, Meng XQ and Zheng SS: Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 10:158–163. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Park Y, Park Y, Lim HS, Kim YS, Hong DJ and Kim HS: Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma. Tissue Antigens. 79:97–103. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fukushima Y, Oshika Y, Nakamura M, Tokunaga T, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Ueyama Y and Tamaoki N: Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. Int J Mol Med. 2:349–351. 1998.PubMed/NCBI | |
|
Ye SR, Yang H, Li K, Dong DD, Lin XM and Yie SM: Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 20:375–383. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zeestraten EC, Reimers MS, Saadatmand S, Goossens-Beumer IJ, Dekker JW, Liefers GJ, van den Elsen PJ, van de Velde CJ and Kuppen PJ: Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer. 110:459–468. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guo ZY, Lv YG, Wang L, Shi SJ, Yang F, Zheng GX, Wen WH and Yang AG: Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immunol. 293:10–16. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu CB, Wang CX, Zhang X, Zhang J and Li W: Serum sHLA-G levels: A useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer. 128:617–622. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM: Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol. 14:2721–2729. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Du L, Xiao X, Wang C, Zhang X, Zheng N, Wang L, Zhang X, Li W, Wang S and Dong Z: Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Sci. 102:1272–1280. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tuncel T, Karagoz B, Haholu A, Ozgun A, Emirzeoglu L, Bilgi O and Kandemir EG: Immunoregulatory function of HLA-G in gastric cancer. Asian Pac J Cancer Prev. 14:7681–7684. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM: Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 128:1002–1009. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lin A, Zhang X, Zhou WJ, Ruan YY, Xu DP, Wang Q and Yan WH: Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Cancer. 129:1382–1390. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hu J, Li L, Liu Y, Chen Y, Liu C, Liang W, Zhao J, Zou H, Cui X, Qi Y, et al: Overexpression of HLA-G Is positively associated with Kazakh esophageal squamous cell carcinoma in Xinjiang, China. Viral Immunol. 26:180–184. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng J, Xu C, Chu D, Zhang X, Li J, Ji G, Hong L, Feng Q, Li X, Wu G, et al: Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Immunol Lett. 161:13–19. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ, Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, et al: Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. Int J Biol Sci. 8:891–900. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Silva TG, Crispim JC, Miranda FA, Hassumi MK, de Mello JM, Simões RT, Souto F, Soares EG, Donadi EA and Soares CP: Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness. Histol Histopathol. 26:1487–1497. 2011.PubMed/NCBI | |
|
Gan LH, Huang LF, Zhang X, Lin A, Xu DP, Wang Q, Wang TJ and Yan WH: Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma. Hum Immunol. 71:899–904. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A and Paul P: Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res. 61:6838–6845. 2001.PubMed/NCBI | |
|
Kren L, Valkovsky I, Dolezel J, Capak I, Pacik D, Poprach A, Lakomy R, Redova M, Fabian P, Krenova Z and Slaby O: HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma. Diagn Pathol. 7:582012. View Article : Google Scholar : PubMed/NCBI | |
|
Ibrahim EC, Allory Y, Commo F, Gattegno B, Callard P and Paul P: Altered pattern of major histocompatibility complex expression in renal carcinoma: Tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol. 162:501–508. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ and Yan WH: Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens. 74:213–221. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li XJ, Zhang X, Lin A, Ruan YY and Yan WH: Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. Hum Immunol. 73:946–949. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nunes LM, Ayres FM, Francescantonio IC, Saddi VA, Avelino MA, Alencar Rde C, Silva RC, Meneghini AJ and Wastowski IJ: Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer. Hum Immunol. 74:447–451. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
de Figueiredo Feitosa NL, Crispim JC, Zanetti BR, Magalhães PK, Soares CP, Soares EG, Neder L, Donadi EA and Maciel LM: HLA-G is differentially expressed in thyroid tissues. Thyroid. 24:585–592. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Morandi F, Levreri I, Bocca P, Galleni B, Raffaghello L, Ferrone S, Prigione I and Pistoia V: Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res. 67:6433–6441. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Morandi F, Scaruffi P, Gallo F, Stigliani S, Moretti S, Bonassi S, Gambini C, Mazzocco K, Fardin P, Haupt R, et al: Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins. PLoS One. 7:e299222012. View Article : Google Scholar : PubMed/NCBI | |
|
Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A and Weller M: A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape. J Immunol. 168:4772–4780. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kren L, Muckova K, Lzicarova E, Sova M, Vybihal V, Svoboda T, Fadrus P, Smrcka M, Slaby O, Lakomy R, et al: Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: A role in innate immunity? J Neuroimmunol. 220:131–135. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kren L, Slaby O, Muckova K, Lzicarova E, Sova M, Vybihal V, Svoboda T, Fadrus P, Lakomy R, Vanhara P, et al: Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance? Neuropathology. 31:129–134. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wastowski IJ, Simões RT, Yaghi L, Donadi EA, Pancoto JT, Poras I, Lechapt-Zalcman E, Bernaudin M, Valable S, Carlotti CG Jr, et al: Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2′-deoxycytidine and interferon-γ treatments: Results from a multicentric study. Am J Pathol. 182:540–552. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gros F, Sebti Y, de Guibert S, Branger B, Bernard M, Fauchet R and Amiot L: Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia. 8:223–230. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Dardano A, Rizzo R, Polini A, Stignani M, Tognini S, Pasqualetti G, Ursino S, Colato C, Ferdeghini M, Baricordi OR and Monzani F: Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: Novel potential biomarkers of disease? J Clin Endocrinol Metab. 97:4080–4086. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJ and Kuppen PJ; Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer, : A retrospective cohort study. Bmc Cancer. 14:4862014. View Article : Google Scholar : PubMed/NCBI | |
|
Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, et al: Polymorphic sites at the 3′ untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS One. 8:e717422013. View Article : Google Scholar : PubMed/NCBI | |
|
Silva ID, Muniz YC, Sousa MC, Silva KR, Castelli EC, Filho JC, Osta AP, Lima MI and Simões RT: HLA-G 3′UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum Immunol. 74:452–458. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Y, Chen S, Jia S, Zhu Z, Gao X, Dong D and Gao Y: Association of HLA-G 3′ UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. Dna Cell Biol. 30:1027–1032. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lau DT, Norris MD, Marshall GM, Haber M and Ashton LJ: HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma. Tissue Antigens. 78:421–427. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E and Roger M; Biomarkers of Cervical Cancer Risk Study Team, : Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer. 131:E312–E319. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L and Hassen E: Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol. 72:150–158. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xu HH, Shi WW, Lin A and Yan WH: HLA-G 3′ untranslated region polymorphisms influence the susceptibility for human papillomavirus infection. Tissue Antigens. 84:216–222. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Eskandari-Nasab E, Hashemi M, Hasani SS, Omrani M, Taheri M and Mashhadi MA: Association between HLA-G 3′UTR 14-bp ins/del polymorphism and susceptibility to breast cancer. Cancer Biomark. 13:253–259. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rolfsen GB, Castelli EC, Donadi EA, Duarte RA and Soares CP: HLA-G polymorphism and breast cancer. Int J Immunogenet. 41:143–148. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Teixeira AC, Mendes-Junior CT, Souza FF, Marano LA, Deghaide NH, Ferreira SC, Mente ED, Sankarankutty AK, Elias-Junior J, Castro-e-Silva O, et al: The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Tissue Antigens. 81:408–413. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SK, Chung JH, Jeon JW, Park JJ, Cha JM, Joo KR, Lee JI and Shin HP: Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection. Hepatogastroenterology. 60:796–798. 2013.PubMed/NCBI | |
|
Yan WH: HLA-G expression in cancers: Potential role in diagnosis, prognosis and therapy. Endocr Metab Immune Disord Drug Targets. 11:76–89. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Teng MW, Galon J, Fridman WH and Smyth MJ: From mice to humans: Developments in cancer immunoediting. J Clin Invest. 125:3338–3346. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kochan G, Escors D, Breckpot K and Guerrero-Setas D: Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology. 2:e264912013. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng XC, Zhang T, Huang DH, Wang GY, Chen W, Li H, Zhang J, Fang TL, Zhang Q and Chen GH: RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma. Ann Clin Lab Sci. 43:135–144. 2013.PubMed/NCBI | |
|
Lin A, Xu HH, Xu DP, Zhang X, Wang Q and Yan WH: Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Hum Immunol. 74:439–446. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lesport E, Baudhuin J, LeMaoult J, Sousa S, Doliger C, Carosella ED and Favier B: Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell. Hum Immunol. 70:1000–1005. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J and Carosella ED: HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA. 100:pp. 1191–1196. 2003; View Article : Google Scholar : PubMed/NCBI | |
|
Zidi I, Guillard C, Marcou C, Krawice-Radanne I, Sangrouber D, Rouas-Freiss N, Carosella ED and Moreau P: Increase in HLA-G1 proteolytic shedding by tumor cells: A regulatory pathway controlled by NF-kappaB inducers. Cell Mol Life Sci. 63:2669–2681. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rodríguez JA, Galeano L, Palacios DM, Gómez C, Serrano ML, Bravo MM and Combita AL: Altered HLA class I and HLA-G expression is associated with IL-10 expression in patients with cervical cancer. Pathobiology. 79:72–83. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tao S, He H, Chen Q and Yue W: GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Biochem Biophys Res Commun. 451:74–78. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED and LeMaoult J: Trogocytosis-based generation of suppressive NK cells. Embo J. 26:1423–1433. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A and Carosella ED: Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood. 109:2040–2048. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Brown R, Kabani K, Favaloro J, Yang S, Ho PJ, Gibson J, Fromm P, Suen H, Woodland N, Nassif N, et al: CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood. 120:2055–2063. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Morandi F, Ferretti E, Bocca P, Prigione I, Raffaghello L and Pistoia V: A novel mechanism of soluble HLA-G mediated immune modulation: Downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS One. 5:e117632010. View Article : Google Scholar : PubMed/NCBI | |
|
Morandi F, Ferretti E, Castriconi R, Dondero A, Petretto A, Bottino C and Pistoia V: Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. Blood. 118:5840–5850. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Naji A, Menier C, Morandi F, Agaugué S, Maki G, Ferretti E, Bruel S, Pistoia V, Carosella ED and Rouas-Freiss N: Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol. 192:1536–1546. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Gu W and Li X: HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation. Placenta. 34:1044–1052. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liang S, Baibakov B and Horuzsko A: HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol. 32:2418–2426. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Agaugué S, Carosella ED and Rouas-Freiss N: Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood. 117:7021–7031. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Loumagne L, Baudhuin J, Favier B, Montespan F, Carosella ED and Rouas-Freiss N: In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance. Int J Cancer. 135:2107–2117. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dong DD, Yie SM, Li K, Li F, Xu Y, Xu G, Song L and Yang H: Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer. Hum Immunol. 73:998–1004. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gallegos CE, Michelin S, Trasci SB, Lobos EA, Dubner D and Carosella ED: HLA-G1 increases the radiosensitivity of human tumoral cells. Cell Immunol. 287:106–111. 2014. View Article : Google Scholar : PubMed/NCBI |
